Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 21, 2017; 23(43): 7678-7692
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7678
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7678
Figure 5 Protein expression of transporters, Cyp7a1, Cyp8b1, Sirt1, and p-AMPKα enzymes in the liver of sham-operated and bile duct-obstructed rats.
Rats were administered either saline or resveratrol (R, 10 mg/kg) daily by oral gavage for 28 d after surgery. The results are presented as a percentage of the saline-administered sham (control) group (A). Representative immunoblots (B). Data are presented as the mean ± SE (n = 6); aP < 0.05, bP < 0.01, eP < 0.001 vs saline-treated sham group; cP < 0.05, dP < 0.01, fP < 0.001 vs saline-treated BDO group. BDO: Bile duct obstruction.
- Citation: Dolezelova E, Prasnicka A, Cermanova J, Carazo A, Hyrsova L, Hroch M, Mokry J, Adamcova M, Mrkvicova A, Pavek P, Micuda S. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol 2017; 23(43): 7678-7692
- URL: https://www.wjgnet.com/1007-9327/full/v23/i43/7678.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i43.7678